KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Amortization - Intangibles (2016 - 2025)

Globus Medical (GMED) has disclosed Amortization - Intangibles for 11 consecutive years, with $29.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization - Intangibles fell 1.85% year-over-year to $29.4 million, compared with a TTM value of $118.2 million through Dec 2025, down 0.99%, and an annual FY2025 reading of $118.2 million, down 0.99% over the prior year.
  • Amortization - Intangibles was $29.4 million for Q4 2025 at Globus Medical, down from $29.8 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $30.2 million in Q2 2025 and bottomed at $4.3 million in Q3 2022.
  • Average Amortization - Intangibles over 5 years is $16.2 million, with a median of $9.3 million recorded in 2021.
  • The sharpest move saw Amortization - Intangibles dropped 5.49% in 2022, then soared 553.38% in 2024.
  • Year by year, Amortization - Intangibles stood at $4.6 million in 2021, then fell by 1.1% to $4.5 million in 2022, then skyrocketed by 524.12% to $28.1 million in 2023, then increased by 6.36% to $29.9 million in 2024, then dropped by 1.85% to $29.4 million in 2025.
  • Business Quant data shows Amortization - Intangibles for GMED at $29.4 million in Q4 2025, $29.8 million in Q3 2025, and $30.2 million in Q2 2025.